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Dtolerate the higher pressures during vaginal delivery. There-
fore, these valves might be suitable for female patients who
want to have children.
We have to construct these valves ourselves, and ePTFE
is slightly stiffer for suturing than homografts and bovine
jugular veins. However, ePTFE valves can be made to any
desired size, are easy to construct, have good biocompatibil-
ity, and are relatively inexpensive. Although further
follow-up is necessary, especially for the small conduits,
the combined effectiveness of the ePTFE conduits and
patches with bulging sinuses and the fan-shaped ePTFE
valves have a low freedom from reoperation and prevent
pulmonary insufficiency, making it a promising material
for RVOT reconstruction.
CONCLUSION
ePTFE has good biocompatibility, making it an ideal ma-
terial for surgical prostheses. A newly developed fan-shaped
valve with bulging sinuses on ePTFE conduits and patches
has beneficial effects on the long-term valve function in
RVOT reconstruction. These valves can accomplish excel-
lent midterm outcomes even with smaller-sized conduits
and can be a promising material for RVOT reconstruction.
We are grateful to all the institutions that were included in this
study for providing data for this manuscript.
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Dr Andres J. Schlichter (Buenos Aires, Argentina). I thank the
authors for sending me the manuscript in advance. I sincerely con-
gratulate them for this nice, neatly presented paper, which I really
enjoyed. It addresses an old and recurrent problem with conduits.
The patients usually outgrow them or their condition tends to de-
teriorate in the years after the so-called correction of the malfor-
mations. Really, no procedure using a conduit to connect the
right ventricle to a pulmonary artery is a correction of the disease.
It is a palliation.
Our group has addressed this problem since 1983 with autolo-
gous pericardial valved conduits. These have been shown to
increase in diameter with the growth of the patient, but unfortu-
nately, their valvular function has a short life. The ePTFE conduit
here shown constructed with bulging sinuses follows the idea
outlined by Leonardo da Vinci more than 500 years ago for the
mechanism of closure of the sigmoid valves.
Apparently, the conduit here presented has a longer functioning
valvular durability, and no degeneration has yet been demon-
strated, as opposed to homografts and other xenografts. The fan-
shaped valves with vortex-like flow are a great improvement.
It is really surprising that even the smaller-sized conduits had
a relatively long follow-up time, some 5 years, before needing ex-
plantation. This is more notable in the smallest sizes, 8 and 10 mm,
which we all would presume to become obstructive very soon after
implantation. The indication for replacement for the conduit wasgery c November 2011
Miyazaki et al Congenital Heart Disease
C
H
Dmostly for obstruction, with pressure gradients of 50 mm Hg.
Maybe you should have divided the conduits into 3 groups: one
from 8 to 14 mm (20 patients), a second, 16 mm to 18 mm, and
a third, 18 mm and larger. Had you done so, do you think that
the smaller conduits would have a significantly shorter life than
the 6-year freedom from reoperation you had for your first group?
DrMiyazaki. I appreciate your comment and I would like to an-
swer your question. As you pointed out, problems with RVOT re-
construction are conduit stenosis, lack of growth potential, and,
most important, the pulmonary regurgitation that will be the late
cause of right ventricular dysfunction. An autologous pericardial
valved conduit is an ideal material from the standpoint of growth
potential. However, we have used autologous pericardial valved
conduits that did not maintain the valve function for a long time,
and we could not identify whether the autologous pericardium
had a growth potential or not. In addition, unfortunately, autologous
pericardial valves have been fraught with early degeneration and in
some cases have caused pulmonary stenosis. Furthermore, because
of legal problems, as well as particular regional reasons, homograft
and bovine jugular veins are unavailable in our country. Therefore,
we have developed handmade ePTFE valves.
To answer your first question: When dividing patients into 3
groups, the freedom from reoperation at 6 years in the smaller con-
duit (8-14 mm) is 60%, in the medium-sized conduit (16-18 mm)
100%, and larger conduit (20-24 mm) 100%. However, small in-
fants cannot escape from the smaller conduit implantation, and I
think that this result is significantly better than the result of
small-sized homografts and is equivalent to or better than the result
with the Contegra valved conduit (Medtronic, Inc, Minneapolis,
Minn). Moreover, the reason for the reoperation was patient
somatic growth, not the dysfunction of the valved conduit.
We decided the indication for conduit replacement was a pres-
sure gradient of 50 mm Hg. However, we try to intervene earlier if
we think that the patient can receive a big enough conduit to pre-
vent right ventricular dysfunction, even if the pressure gradient is
less than 50 mm Hg.
Dr Schlichter. That is a very nice answer.
Regarding the patches, you state that on some occasions you re-
construct the posterior wall with autologous pericardium and then
complete the outflow tract by placing the ePTFE valve anteriorly.
My second question is in 2 parts. First, do you suture ePTFE
valves on the posterior right ventricular–pulmonary artery conti-
nuity, too? Second, if you do not suture a valve on the posterior as-
pect of the outflow and you use only a monocusp on the patch, do
you suspect that this may be the cause for a higher percent of pul-
monary incompetence in the patients in the patch group as com-
pared with the conduit group? The anterior cusps may coapt
with the posterior wall at the time of surgery, but when the poste-
rior aspect dilates or grows, it may be foreseen that the ePTFE
valves will not coapt any more.
DrMiyazaki. To answer the first question, yes, we sutured a bi-
cuspid fan-shaped ePTFE valve to the posterior pericardial right
ventricle–pulmonary artery continuity. However, we do not have
data on how to reconstruct the posterior right ventricle–pulmonary
artery continuity at the other institutions involved in this study.The Journal of Thoracic and CarTo answer the second question, when we reconstruct the RVOT
using a monocuspid patch and valveless autologous pericardium,
I suspect this might be the cause for the higher percentage of
pulmonary incompetence.
We think that the growth potential is the other important factor
for small children, and we are using the autologous material for the
posterior wall reconstruction. The majority of patients who need
RVOT reconstruction with autologous pericardium in the posterior
wall and the monocuspid patch in the anterior wall had more com-
plex anatomy such as truncus arteriosus. However, as you indi-
cated, the growing or dilating posterior wall may end up with
noncoapting leaflets that were initially working well, so we have
developed a fan-shaped valve that has a long circular margin
that possesses a large coaptation zone.
Furthermore, we used patches in cases of tetralogy of Fallot or
other congenital cardiac disorders with a narrow pulmonary annu-
lus. In our series, the patients with patches had a greater chance to
have a moderate amount of regurgitation in the long-term than the
patients with conduits. This might be due to the quality of the
native valve, which makes up the posterior wall of the RVOT.
The native valves are very likely to degenerate and cause pulmo-
nary stenosis. When the ePTFE valve leaflets are sutured on the
autologous posterior wall, they are not expected to provide long-
lasting good valve function because of the lack of sinuses.
In addition, in the case of severe pulmonary stenosis like a fish-
mouth pulmonary valve, we prefer a conduit for RVOT reconstruc-
tion, because the native valves are not expected to have sufficient
valve function.
Dr Schlichter.My last question is this: Are you expecting these
ePTFE 0.1-mm membrane valves to have a very long functioning
life or are you suspecting that these will deteriorate with time, too?
I think the incorporation of a longer-lasting valvular function with
the ePTFE fan-shaped valves with bulging sinuses and vortex-like
flow are really an important improvement. Unfortunately, although
an excellent material, PTFE still does not grow, so that the small-
sized conduits will still have to be replaced at least once.
I want to commend your group for the important work done in
this field.
Dr Miyazaki. Indeed, we have used fan-shaped ePTFE valves
without bulging sinuses for over 20 years, and most patients still
have demonstrated a good motion of the leaflet valve. We expect
the 0.1-mm ePTFE membrane valves to have a long valve function
thanks to the bulging sinuses.
Furthermore, Japanese are relatively small built, so we think an
18-mm conduit for female and a 22-mm conduit for male subjects
could stand long use. Although further follow-up will be necessary,
there is a high possibility that reoperation owing to the patient’s
growth and body weight gain is avoidable in both conduit sizes.
DrThoralf Sundt (Boston,Mass). I have a quick question about
biocompatibility.Youmentioned the potential for tissue ingrowth. I
am surprised that tissue ingrowth does not make the valves stiff.
What is the character of the tissue ingrowth to the ePTFE?
Dr Miyazaki. We have no evidence of pannus formation and
calcification that make the valves stiff. I think the reason is that
the valves keep in motion thanks to the bulging sinuses.diovascular Surgery c Volume 142, Number 5 1129
